Revenue and Profit - Revenue for Q3 2022 reached ¥1,451,758,944.54, an increase of 4.59% year-over-year, while year-to-date revenue totaled ¥4,801,169,919.31, up 51.66% compared to the same period last year[7] - Net profit attributable to shareholders for Q3 2022 was ¥163,321,575.17, a decrease of 20.24% year-over-year, with year-to-date net profit at ¥661,555,976.07, reflecting a 76.03% increase[7] - Basic earnings per share for Q3 2022 was ¥0.17, down 54.05% year-over-year, while year-to-date basic earnings per share stood at ¥1.08, up 58.82%[7] - Total operating revenue for the current period reached ¥4,801,169,919.31, a significant increase of 51.6% compared to ¥3,165,768,111.58 in the previous period[25] - Operating profit for the current period was ¥882,149,379.90, up 81.6% from ¥485,810,537.45 in the previous period[27] - Net profit attributable to shareholders of the parent company was ¥661,555,976.07, representing a 76.0% increase from ¥375,829,111.24 in the previous period[27] - The company reported a total profit of ¥876,564,977.86, an increase of 80.6% compared to ¥485,461,971.89 in the previous period[27] - The basic earnings per share rose to ¥1.08, compared to ¥0.68 in the previous period, marking a 58.8% increase[27] Assets and Liabilities - Total assets as of the end of Q3 2022 amounted to ¥10,122,724,789.90, representing an 81.13% increase from the end of the previous year[7] - The company's total current assets amounted to CNY 8,967,517,318.55, compared to CNY 4,695,105,050.89 in the same period last year, reflecting a growth of approximately 91.5%[19] - The total liabilities of the company were CNY 3,249,958,426.55, up from CNY 2,811,546,417.05, indicating an increase of about 15.6%[21] - The equity attributable to the parent company reached CNY 6,583,825,847.99, compared to CNY 2,554,183,024.95 in the previous year, marking an increase of approximately 158.5%[24] - The total owner's equity amounted to CNY 6,872,766,363.35, up from CNY 2,777,197,771.58, indicating a growth of around 147.5%[24] Cash Flow - Cash flow from operating activities for the year-to-date was ¥643,287,872.23, a remarkable increase of 740.36% compared to the same period last year[12] - Cash flow from operating activities generated a net amount of ¥643,287,872.23, a turnaround from a negative cash flow of ¥100,457,075.72 in the previous period[31] - Cash inflow from operating activities totaled ¥3,677,447,138.44, compared to ¥1,714,493,605.14 in the previous period, indicating a growth of 114.3%[31] - The company experienced a net cash outflow from investing activities of ¥302,645,279.08, an improvement from a larger outflow of ¥869,812,395.49 in the previous period[31] - Cash inflow from financing activities totaled approximately $3.95 billion, a significant increase compared to $110.67 million in the previous period[33] - Net cash flow from financing activities reached approximately $3.65 billion, up from $97.32 million year-over-year[33] - The net increase in cash and cash equivalents was approximately $4.04 billion, contrasting with a decrease of $891.13 million in the prior period[33] - The ending balance of cash and cash equivalents stood at approximately $4.92 billion, compared to $202.23 million in the previous period[33] - The impact of exchange rate changes on cash and cash equivalents was approximately $47.85 million, compared to a negative impact of $18.18 million previously[33] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 60,322, with the largest shareholder, Jiangsu Guotai International Group Co., Ltd., holding 68.18% of shares[13] - The company completed its IPO, resulting in a substantial increase in capital reserves by 648.39% to ¥3,698,999,112.52[12] - The company reported a net cash inflow from financing activities of ¥3,651,926,451.55, a significant increase of 3652.55% due to the IPO[12] Research and Development - Research and development expenses for the year-to-date were ¥100,134,280.03, an increase of 39.36% year-over-year, indicating a commitment to maintaining technological leadership[12] - Research and development expenses increased to ¥100,134,280.03, up 39.5% from ¥71,853,447.23 in the previous period[25]
瑞泰新材(301238) - 2022 Q3 - 季度财报